Sort
261,768 grants matching “gene therapy”
Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT)
$1,039,095Adam Wayne Carrico · University Of Miami School Of Medicine · R01 · FY2022 · MH
A novel immunotolerizing therapy for autoimmune vitiligo
$1,039,086Kanneganti Murthy · Radikal Therapeutics, Inc. · R44 · FY2017 · AR
Reading mitochondrial apoptotic signaling to identify active cancer therapeutics
$1,038,996Anthony G Letai · Dana-Farber Cancer Inst · R35 · FY2022 · CA
Colorectal Cancer (CRC) Prevention by Urolithin A in Rodent CRC models
$1,038,958Margie L. Clapper · Research Inst Of Fox Chase Can Ctr · N01 · FY2023 · CA
RESTORATION OF APOPTOSIS IN CANCER
$1,038,933University Of Texas Md Anderson Can Ctr · P01 · FY2000 · CA
Therapy for NF1-Related Tumors and other Genetic Tumor Predisposition Syndromes
$1,038,724Brigitte Widemann · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Etiological Studies of Gastric Carcinoma
$1,038,693Keith T Wilson · Vanderbilt University Medical Center · P01 · FY2017 · CA
Pathway and GWAS SNPs: Role in SCCHN Risk, Outcome and Treatment Response
$1,038,578Brenda Diergaarde · University Of Pittsburgh At Pittsburgh · P50 · FY2011 · CA
National Center for Canine Models of Duchenne Muscular Dystrophy (NCDMD)
$1,038,570Joe N Kornegay · Univ Of North Carolina Chapel Hill · U24 · FY2009 · NS
National Center for Canine Models Muscular Dystrophy (NCDMD)
$1,038,570Joe N Kornegay · Univ Of North Carolina Chapel Hill · U24 · FY2009 · NS
MODEL SYSTEMS TOWARD DEVELOPMENT OF HUMAN GENE THERAPY
$1,038,500University Of Pittsburgh At Pittsburgh · P01 · FY2003 · DK
Tracking longitudinal change in presymptomatic genetic prion disease (TLC-Pre-gPrD)
$1,038,413Michael D Geschwind · University Of California, San Francisco · R01 · FY2020 · AG
Signaling in the retina and retinal pigment epithelium
$1,038,271Thomas Redmond · National Eye Institute · ZIA · FY2019 · EY
CD19-Specific Central Memory T Cell Adoptive Immunotherapy for Non-Hodgkin Lymphoma
$1,038,189Andrew A. Raubitschek · Beckman Research Institute/City Of Hope · P50 · FY2015 · CA
Targeting SIV macrophage reservoirs in the CNS by CSF1R inhibition
$1,038,147Woong-Ki Kim · Tulane University Of Louisiana · R01 · FY2023 · MH
A Novel Therapeutic for Liver Fibrosis
$1,038,130Prakash Narayan · Angion Biomedica Corporation · R44 · FY2013 · AA
Basic and Translational Studies of Cystic Fibrosis
$1,038,005Raymond A Frizzell · University Of Pittsburgh At Pittsburgh · P30 · FY2017 · DK
SBIR TOPIC 257, INSTRUMENTS AND DEVICES THAT PRESERVE MOLECULAR PROFILES IN TUMO
$1,037,959Adam Schayowitz · Biomarker Strategies, Llc · N43 · FY2011 · CA
Improved Chimeric Antigen Receptor Therapies B-cell Malignancies
$1,037,952James Kochenderfer · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
In Vivo Cellular and Molecular Imaging Centers (ICMICs)
$1,037,769Robert F Mattrey · University Of California, San Diego · P50 · FY2012 · CA
Computational Modeling Core
$1,037,741Katrina M. Waters · University Of Wisconsin-Madison · U19 · FY2017 · AI
Identifying therapeutic targets that confer synaptic resilience to Alzheimer's disease
$1,037,676Jeremy H. Herskowitz · University Of Alabama At Birmingham · R01 · FY2019 · AG
Neuroengineering a Robust Vocal Learning Phenotype in Mice as a Model for Treating Communication Disorders
$1,037,645Erich D Jarvis · Rockefeller University · R01 · FY2019 · DC
A two-pronged approach to generating novel models of photoreceptor degeneration for regenerative cell therapy
$1,037,547Yingbin Fu · Baylor College Of Medicine · U24 · FY2021 · EY
Virus and olfactory system interactions accelerate Alzheimer's disease pathology
$1,037,518Diego Restrepo · University Of Colorado Denver · R01 · FY2023 · AG